|
US4816570A
(en)
|
1982-11-30 |
1989-03-28 |
The Board Of Regents Of The University Of Texas System |
Biologically reversible phosphate and phosphonate protective groups
|
|
US4649041A
(en)
*
|
1983-07-20 |
1987-03-10 |
Warner-Lambert Company |
Magnesium trisilicate suitable for preparation of medicament adsorbates of antinauseants
|
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
|
US4968788A
(en)
|
1986-04-04 |
1990-11-06 |
Board Of Regents, The University Of Texas System |
Biologically reversible phosphate and phosphonate protective gruops
|
|
US5455339A
(en)
|
1986-05-01 |
1995-10-03 |
University Of Georgia Research Foundation, Inc. |
Method for the preparation of 2',3'-dideoxy and 2',3'-dideoxydide-hydro nucleosides
|
|
IE63869B1
(en)
|
1986-11-06 |
1995-06-14 |
Res Dev Foundation |
Aerosols containing liposomes and method for their preparation
|
|
FR2611203B1
(fr)
|
1987-02-20 |
1989-06-09 |
Sturtz Georges |
Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2737191B2
(ja)
*
|
1987-12-28 |
1998-04-08 |
東ソー株式会社 |
均質な石英ガラス塊の製造方法
|
|
US5631370A
(en)
|
1988-01-20 |
1997-05-20 |
Regents Of The University Of Minnesota |
Optically-active isomers of dideoxycarbocyclic nucleosides
|
|
US5466793A
(en)
|
1988-03-01 |
1995-11-14 |
Ajinomoto Co., Inc. |
Process for preparing 2', 3'- dideoxyinosine
|
|
ZA894534B
(en)
|
1988-06-20 |
1990-03-28 |
Merrell Dow Pharma |
Novel neplanocin derivatives
|
|
CA2001715C
(en)
|
1988-11-14 |
1999-12-28 |
Muzammil M. Mansuri |
Carbocyclic nucleosides and nucleotides
|
|
US5744600A
(en)
|
1988-11-14 |
1998-04-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Phosphonomethoxy carbocyclic nucleosides and nucleotides
|
|
US5202128A
(en)
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
|
JP2722673B2
(ja)
|
1989-05-31 |
1998-03-04 |
住友化学工業株式会社 |
光学活性なアシルビフェニル誘導体の製造法
|
|
DE4003574A1
(de)
|
1990-02-07 |
1991-08-08 |
Bayer Ag |
Neue dipeptide, verfahren zu ihrer herstellung und ihre verwendung als renininhibitoren in arzneimitteln
|
|
ATE131825T1
(de)
|
1990-06-13 |
1996-01-15 |
Arnold Glazier |
Phosphorylierte prodrugs
|
|
DK0465297T3
(da)
|
1990-07-04 |
1996-02-19 |
Merrell Pharma Inc |
9-Purinylphosphonsyre-derivater
|
|
US5177064A
(en)
|
1990-07-13 |
1993-01-05 |
University Of Florida |
Targeted drug delivery via phosphonate derivatives
|
|
EP0468119A1
(en)
|
1990-07-24 |
1992-01-29 |
Merrell Dow Pharmaceuticals Inc. |
Novel carbocyclic analogs of certain nucleosides
|
|
US5223618A
(en)
|
1990-08-13 |
1993-06-29 |
Isis Pharmaceuticals, Inc. |
4'-desmethyl nucleoside analog compounds
|
|
EP0481214B1
(en)
|
1990-09-14 |
1998-06-24 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Prodrugs of phosphonates
|
|
US5672697A
(en)
|
1991-02-08 |
1997-09-30 |
Gilead Sciences, Inc. |
Nucleoside 5'-methylene phosphonates
|
|
DE4111730A1
(de)
|
1991-04-10 |
1992-10-15 |
Knoll Ag |
Neue cytarabin-derivate, ihre herstellung und verwendung
|
|
JP2648897B2
(ja)
|
1991-07-01 |
1997-09-03 |
塩野義製薬株式会社 |
ピリミジン誘導体
|
|
EP0531597A1
(en)
|
1991-09-12 |
1993-03-17 |
Merrell Dow Pharmaceuticals Inc. |
Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
|
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
DE4138584A1
(de)
|
1991-11-23 |
1993-05-27 |
Hoechst Ag |
Carbocyclische phosphonat-nucleotidanaloge, deren herstellung und verwendung
|
|
GB9126144D0
(en)
|
1991-12-10 |
1992-02-12 |
British Bio Technology |
Compounds
|
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
|
DE4308096A1
(de)
|
1993-03-13 |
1994-09-15 |
Hoechst Ag |
Prodrug-Derivate von Enzyminhibitoren mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
|
|
US5654286A
(en)
|
1993-05-12 |
1997-08-05 |
Hostetler; Karl Y. |
Nucleotides for topical treatment of psoriasis, and methods for using same
|
|
ATE199906T1
(de)
|
1993-06-29 |
2001-04-15 |
Mitsubishi Chem Corp |
Phosphonat-nukleotid ester-derivate
|
|
EP0708760A1
(en)
|
1993-07-14 |
1996-05-01 |
Novartis AG |
Cyclic hydrazine compounds
|
|
DE69435319D1
(de)
|
1993-09-17 |
2010-12-16 |
Gilead Sciences Inc |
Nukleotidanaloge
|
|
US5656745A
(en)
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5493030A
(en)
|
1994-02-18 |
1996-02-20 |
Syntex (U.S.A.) Inc. |
5-substituted derivatives of mycophenolic acid
|
|
US5854227A
(en)
|
1994-03-04 |
1998-12-29 |
Hartmann; John F. |
Therapeutic derivatives of diphosphonates
|
|
EP0786455B1
(en)
|
1994-09-26 |
2003-12-03 |
Shionogi & Co., Ltd. |
Imidazole derivative
|
|
EP0789695A2
(en)
|
1994-11-04 |
1997-08-20 |
Gilead Sciences, Inc. |
Thiepane compounds inhibiting and detecting hiv protease
|
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
|
ES2097703B1
(es)
|
1995-04-12 |
1997-12-01 |
Decox S L |
Una nueva composicion estimulante de la actividad cerebral basada en alcaloides de nucleo de eburnamenina, y sus metodos de preparacion.
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
EP0836604A1
(en)
|
1995-06-29 |
1998-04-22 |
Novo Nordisk A/S |
Novel substituted azabicyclic compounds
|
|
US5750493A
(en)
|
1995-08-30 |
1998-05-12 |
Raymond F. Schinazi |
Method to improve the biological and antiviral activity of protease inhibitors
|
|
EP0852233A4
(en)
|
1995-09-21 |
1999-09-15 |
Nippon Shinyaku Co Ltd |
CYCLOSPORIN PHOSPHATE DERIVATIVES AND MEDICINAL COMPOSITION
|
|
US5914332A
(en)
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
|
RU2106353C1
(ru)
|
1996-03-19 |
1998-03-10 |
Корпорация "С энд Ти Сайенс энд Текнолоджи Инк." |
Соли 5'-н-фосфоната 3'- азидо-3'-дезокситимидина, являющиеся специфическими ингибиторами продукции вируса иммунодефицита человека вич-1 и вич-2
|
|
US5656746A
(en)
*
|
1996-03-28 |
1997-08-12 |
The Proctor & Gamble Company |
Temporary wet strength polymers from oxidized reaction product of polyhydroxy polymer and 1,2-disubstituted carboxylic alkene
|
|
US5874577A
(en)
|
1996-04-03 |
1999-02-23 |
Medichem Research, Inc. |
Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
|
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
WO1998004569A1
(en)
|
1996-07-26 |
1998-02-05 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US6194398B1
(en)
|
1996-08-13 |
2001-02-27 |
Mitsubishi Chemical Corporation |
Phosphonate nucleotide compound
|
|
AU4892897A
(en)
|
1996-09-17 |
1998-04-14 |
Amur Pharmaceuticals, Inc. |
Phospholipid drug derivatives
|
|
JP4118958B2
(ja)
|
1996-10-09 |
2008-07-16 |
ファーマセット，リミティド |
テトラホスホネート二環式トリス無水物
|
|
EP0994106B1
(en)
|
1996-12-26 |
2004-03-17 |
Shionogi & Co., Ltd. |
Process for the preparation of carbamoylated imidazole derivatives
|
|
WO1999029702A2
(en)
|
1997-12-10 |
1999-06-17 |
The Government Of The United States Of America Reppresented By The Secretary, Department Of Health And Human Services |
METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA)
|
|
US6436989B1
(en)
|
1997-12-24 |
2002-08-20 |
Vertex Pharmaceuticals, Incorporated |
Prodrugs of aspartyl protease inhibitors
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
US6174888B1
(en)
|
1998-05-28 |
2001-01-16 |
Novartis Ag |
2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
|
|
WO1999062921A1
(en)
|
1998-06-01 |
1999-12-09 |
S & T Science And Technology Inc. |
Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
|
|
GB9815567D0
(en)
|
1998-07-18 |
1998-09-16 |
Glaxo Group Ltd |
Antiviral compound
|
|
TWI260322B
(en)
|
1999-02-12 |
2006-08-21 |
Vertex Pharma |
Inhibitors of aspartyl protease
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
HK1043796B
(en)
|
1999-03-05 |
2007-02-23 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing prodrugs
|
|
DE19912636A1
(de)
|
1999-03-20 |
2000-09-21 |
Aventis Cropscience Gmbh |
Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel
|
|
US6258831B1
(en)
|
1999-03-31 |
2001-07-10 |
The Procter & Gamble Company |
Viral treatment
|
|
US6608027B1
(en)
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
|
DE19927689A1
(de)
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
|
AU780973B2
(en)
|
1999-06-25 |
2005-04-28 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of carbamate inhibitors of IMPDH
|
|
US6581606B2
(en)
|
1999-07-06 |
2003-06-24 |
The Rx Files Corporation |
Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
|
|
JP2003507438A
(ja)
|
1999-08-24 |
2003-02-25 |
セルゲイト， インコーポレイテッド |
オリゴアルギニン部分を使用する上皮組織を横切るおよび上皮組織内への薬物送達の増強
|
|
GB9920872D0
(en)
|
1999-09-04 |
1999-11-10 |
Glaxo Group Ltd |
Benzophenones as inhibitors of reverse transcriptase
|
|
IL131887A0
(en)
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
|
DE60038038T2
(de)
|
1999-12-03 |
2009-02-12 |
The Regents of The University of California at San Diego, La Jolla |
Phosphonatverbindungen
|
|
WO2001046204A1
(en)
|
1999-12-22 |
2001-06-28 |
Merck Frosst Canada & Co. |
Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
|
|
US6767900B2
(en)
|
2000-02-29 |
2004-07-27 |
Mitsubishi Pharma Corporation |
Phosphonate nucleotide compound
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
HUP0301713A3
(en)
|
2000-06-13 |
2005-04-28 |
Shionogi & Co |
Pharmaceutical compositions containing propenone derivatives and their use
|
|
FR2810322B1
(fr)
|
2000-06-14 |
2006-11-10 |
Pasteur Institut |
PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP)
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
US6617310B2
(en)
|
2000-07-19 |
2003-09-09 |
Bristol-Myers Squibb Pharma Company |
Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
|
|
MXPA03000587A
(es)
|
2000-07-21 |
2004-04-05 |
Gilead Sciences Inc |
Profarmacos de analogos de nucleotido de fosfonato y metodos para seleccionar y elaborar los mismos.
|
|
US6420586B1
(en)
|
2000-08-15 |
2002-07-16 |
University Of Kansas |
Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
|
|
ATE343384T1
(de)
|
2000-09-08 |
2006-11-15 |
Zeria Pharm Co Ltd |
Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
|
|
RU2188203C2
(ru)
|
2000-10-05 |
2002-08-27 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
2',3'-дидегидро-2',3'-дидезокситимидин-5'[(этоксикарбонил)(этил)фосфонат]- ингибитор репродукции вируса иммунодефицита человека
|
|
GB0028429D0
(en)
|
2000-11-22 |
2001-01-10 |
Astrazeneca Ab |
Therapy
|
|
US20040266723A1
(en)
|
2000-12-15 |
2004-12-30 |
Otto Michael J. |
Antiviral agents for treatment of Flaviviridae infections
|
|
RU2317302C2
(ru)
*
|
2000-12-28 |
2008-02-20 |
Киссеи Фармасьютикал Ко., Лтд. |
Производные глюкопиранозилоксипиразола и их применение в лекарственных средствах
|
|
SI1355916T1
(sl)
|
2001-01-22 |
2007-04-30 |
Merck & Co Inc |
Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze
|
|
CZ20032001A3
(en)
|
2001-01-31 |
2004-06-16 |
Warner-Lambert Company Llc |
Method for carbamoylating alcohols
|
|
DE60221642T3
(de)
|
2001-02-12 |
2017-10-26 |
Wyeth LLC (n.d.Ges.d. Staates Delaware) |
O-desmethyl-venlafaxine succinat salz
|
|
US6962684B2
(en)
|
2001-05-31 |
2005-11-08 |
Sumitomo Chemical Company, Limited |
Activated alumina formed body and method for producing the same
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
KR20020097384A
(ko)
|
2001-06-20 |
2002-12-31 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
|
|
CA2451524A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Templated molecules and methods for using such molecules
|
|
ES2315411T3
(es)
|
2001-07-20 |
2009-04-01 |
Bioagency Ag |
Compuestos organofosforados para la activacion de celulas t gamma/delta.
|
|
JPWO2003016286A1
(ja)
|
2001-08-17 |
2004-12-02 |
三共アグロ株式会社 |
３−フェノキシ−４−ピリダジノール誘導体及びそれを含有する除草剤組成物
|
|
JP2005508924A
(ja)
|
2001-08-30 |
2005-04-07 |
三菱ウェルファーマ株式会社 |
抗ウイルス剤
|
|
DE60209929T2
(de)
*
|
2001-11-29 |
2006-11-16 |
Pfizer Products Inc., Groton |
Succinatsalze von 58;8;14-triatetracyclo[10.3.1.0 2,11 .0 4,9]-hexadeca-2,11,3,5,7,9,-pentaen und pharmazeutische zusammensetzungen
|
|
KR20050044587A
(ko)
|
2001-12-07 |
2005-05-12 |
미쯔비시 웰 파마 가부시키가이샤 |
Ｂ형 간염 바이러스 감염 치료용 포스포네이트뉴클레오타이드 유사체의 용도
|
|
HRP20040530A2
(en)
*
|
2001-12-12 |
2004-10-31 |
Pfizer Prod Inc |
Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
|
|
CN101367834B
(zh)
|
2001-12-21 |
2012-04-18 |
卫才公司 |
用于制备醇和酚的水溶性膦酰氧基甲基衍生物的方法
|
|
US20030198666A1
(en)
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
|
CN101717410B
(zh)
|
2002-02-01 |
2015-04-29 |
阿里亚德医药股份有限公司 |
含磷化合物及其应用
|
|
WO2003066005A2
(en)
|
2002-02-08 |
2003-08-14 |
Conforma Therapeutics Corporation |
Ansamycins having improved pharmacological and biological properties
|
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
WO2003080078A1
(en)
|
2002-03-18 |
2003-10-02 |
Mitsubishi Pharma Corporation |
Treatment of pre-core hepatitis b virus mutant infections
|
|
US6958349B2
(en)
|
2002-04-10 |
2005-10-25 |
Ortho-Mcneil Pharmaceuticals, Inc. |
Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
|
|
US20050239054A1
(en)
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
|
US6872827B2
(en)
*
|
2002-04-26 |
2005-03-29 |
Chembridge Research Laboratories, Inc. |
Somatostatin analogue compounds
|
|
NZ535828A
(en)
|
2002-04-26 |
2007-10-26 |
Gilead Sciences Inc |
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
|
|
US6808572B2
(en)
*
|
2002-05-15 |
2004-10-26 |
Aerojet-General Corporation |
Solid propellant formulations and methods and devices employing the same for the destruction of airborne biological and/or chemical agents
|
|
WO2004029046A2
(en)
|
2002-09-30 |
2004-04-08 |
A/S Gea Farmaceutisk Fabrik |
Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
|
|
AU2003290816A1
(en)
|
2002-11-12 |
2004-06-03 |
Pharmasset, Inc. |
Modified nucleosides as antiviral agents
|
|
US7589078B2
(en)
|
2003-02-19 |
2009-09-15 |
Yale University |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
|
|
MXPA05011294A
(es)
|
2003-04-25 |
2006-03-15 |
Gilead Sciences Inc |
Compuestos de fosfonato anti-inflamatorios.
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
NZ542343A
(en)
|
2003-04-25 |
2009-03-31 |
Gilead Sciences Inc |
Immunomodulator phosphonate conjugates
|
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
KR20060061930A
(ko)
|
2003-04-25 |
2006-06-08 |
길리애드 사이언시즈, 인코포레이티드 |
항암성 포스포네이트 유사체
|
|
DK1628685T3
(da)
|
2003-04-25 |
2011-03-21 |
Gilead Sciences Inc |
Antivirale phosphonatanaloge
|
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
WO2004096233A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
WO2004096237A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
EA200501676A1
(ru)
|
2003-04-25 |
2006-04-28 |
Джилид Сайэнс, Инк. |
Фосфонатсодержащие ингибиторы киназы (варианты), способ их получения, фармацевтическая композиция, лекарственная форма на их основе и способ ингибирования киназы у млекопитающего (варианты)
|
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
EP1626950A4
(en)
|
2003-05-23 |
2007-05-23 |
Transform Pharmaceuticals Inc |
SERTRALINZUSAMMENSETZUNGEN
|
|
KR100933185B1
(ko)
|
2003-06-16 |
2009-12-22 |
아지노모토 가부시키가이샤 |
이노신 유도체 및 이의 제조방법
|
|
AU2004260789B2
(en)
|
2003-07-30 |
2011-06-30 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
|
WO2005016901A1
(en)
*
|
2003-08-18 |
2005-02-24 |
H. Lundbeck A/S |
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
|
CA2543142A1
(en)
|
2003-10-24 |
2005-05-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
|
MXPA06007095A
(es)
|
2003-12-22 |
2006-09-04 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de cinasa.
|
|
CN1906196A
(zh)
|
2003-12-22 |
2007-01-31 |
吉里德科学公司 |
具有hiv和hcv抗病毒活性的4＇－取代的卡波韦－和阿巴卡韦－衍生物以及相关化合物
|
|
EP1550665A1
(en)
|
2003-12-26 |
2005-07-06 |
Ajinomoto Co., Inc. |
A process for the production of purine nucleoside compounds
|
|
US7404949B2
(en)
|
2004-03-15 |
2008-07-29 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Methods and compositions useful to prevent in-grown hair arising from shaving
|
|
EP1758653A2
(en)
|
2004-06-17 |
2007-03-07 |
Osteologix A/S |
Treatments comprising strontium for rheumatic and arthritic diseases and pain
|
|
AU2005330489B2
(en)
*
|
2004-07-27 |
2011-08-25 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates as anti HIV agents
|
|
WO2006015262A2
(en)
|
2004-07-29 |
2006-02-09 |
Coherix, Inc. |
Method for processing multiwavelength interferometric imaging data
|
|
US20060069060A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Sanjeev Redkar |
Salts of decitabine
|
|
US7154505B2
(en)
|
2004-11-11 |
2006-12-26 |
Stonecube Limited |
Method of and apparatus for generating a representation of an object
|
|
KR20060080817A
(ko)
|
2005-01-06 |
2006-07-11 |
씨제이 주식회사 |
시부트라민의 디카복실산염
|
|
MY148074A
(en)
|
2005-05-10 |
2013-02-28 |
Novartis Ag |
Pharmaceutical compositions comprising imatinib and a release retardant
|
|
RU2008107873A
(ru)
*
|
2005-08-04 |
2009-09-10 |
Новартис АГ (CH) |
Новые соединения
|
|
DE102005041860A1
(de)
|
2005-09-02 |
2007-03-08 |
Schering Ag |
Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
|
|
CA2632540A1
(en)
*
|
2005-12-16 |
2007-07-05 |
Wyeth |
Lyophilized compositions of a triazolopyrimidine compound
|
|
US20060223820A1
(en)
*
|
2006-03-21 |
2006-10-05 |
Chemagis Ltd. |
Crystalline aripiprazole salts and processes for preparation and purification thereof
|
|
US8895531B2
(en)
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
|
WO2007139938A2
(en)
*
|
2006-05-26 |
2007-12-06 |
Z Corporation |
Apparatus and methods for handling materials in a 3-d printer
|
|
ES2779826T3
(es)
|
2007-02-23 |
2020-08-20 |
Gilead Sciences Inc |
Moduladores de propiedades farmacocinéticas de agentes terapéuticos
|
|
US20090163449A1
(en)
|
2007-12-20 |
2009-06-25 |
Eastman Chemical Company |
Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or additives
|
|
PE20110219A1
(es)
*
|
2008-07-08 |
2011-03-31 |
Gilead Sciences Inc |
Sales del compuesto n-[(s)({[(2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il]oxi}metil)fenoxifosfinoil]-l-alaninato de etilo como inhibidores de vih
|
|
JP4330086B1
(ja)
|
2009-02-09 |
2009-09-09 |
株式会社テクネス |
非酸化物セラミックス製品の製造方法
|
|
EP2305680A3
(en)
|
2009-09-30 |
2011-05-18 |
Aurobindo Pharma Limited |
Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
|
|
US20140094485A1
(en)
|
2012-10-03 |
2014-04-03 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor
|
|
WO2014055603A1
(en)
|
2012-10-03 |
2014-04-10 |
Gilead Sciences, Inc. |
Process for the preparation of an hiv integrase inhibitor
|